PNEUMOCOCCAL INFECTION IN CHILDREN: EVERYDAY PRACTICE
https://doi.org/10.15690/vsp.v11i4.361
Abstract
The detailed analysis of official guidelines aiming optimization of diagnostics and treatment of home-acquired pneumonia (HAP) in children shows, that a number of diagnostic and therapeutic approaches to this condition are not always evidence-based. Everyday clinical practice demonstrates, that diagnostics and treatment of HAP in children do not often correlate with any of the present standards.The aim of this study is to discuss difficult and unresolved questions of HAP diagnostics and treatment in infants and young children, basing on the analysis of real clinical cases.
About the Authors
L. S. Namazova-Baranova
Scientific Centre of Children Health, RAMS, Moscow;
I.M. Setchenov First Moscow State Medical University;
N.I. Pirogov Russian National Research Medical University, Moscow
Russian Federation
Russian Federation
T. V. Kulichenko
Scientific Centre of Children Health, RAMS, Moscow;
I.M. Setchenov First Moscow State Medical University
Russian Federation
Tat’yana Kulichenko, Candidate of Medical Science, pediatrician, head of the department of urgent pediatrics with group of anesthesiology reanimation of Scientific Research Institute of Preventive Pediatrics and Recovery Treatment
Russian Federation
Tat’yana Kulichenko, Candidate of Medical Science, pediatrician, head of the department of urgent pediatrics with group of anesthesiology reanimation of Scientific Research Institute of Preventive Pediatrics and Recovery Treatment
A. E. Malakhova
Scientific Centre of Children Health, RAMS, Moscow
Russian Federation
Russian Federation
E. V. Starovoitova
Scientific Centre of Children Health, RAMS, Moscow
Russian Federation
Russian Federation
M. D. Bakradze
Scientific Centre of Children Health, RAMS, Moscow;
I.M. Setchenov First Moscow State Medical University
Russian Federation
Russian Federation
I. L. Chashchina
Scientific Centre of Children Health, RAMS, Moscow
Russian Federation
Russian Federation
I. L. Mitushin
Scientific Centre of Children Health, RAMS, Moscow
Russian Federation
Russian Federation
References
1. Principi N., Esposito S. Management of severe communityacquired pneumonia of children in developing and developed countries. Thorax. 2011; 66: 815–822.
2. Harris M., Clark J., Coote N. et al. British Thoracic Society guidelines for the management of community acquired pneumonia in children: update 2011. Thorax. 2011; 66 (2): 1–23.
3. Bradley J. S., Byington C. L., Shah S. S. et al. Executive summary: the management of community-acquired pneumonia in infants and children older than 3 months of age — clinical practice guidelines by the Pediatric Infectious Diseases Society and the Infectious Diseases Society of America. Clin. Infect. Dis. 2011; 53: 617–630.
4. World Health Organization. Pneumonia. Fact sheet No. 331. 2009. http://www.who.int/mediacentre/factsheets/fs331/en/index. html. [Accessed 7 September 2010].
5. Neuman M. I., Monuteaux M. C., Scully K. J., Bachur R. G. Pre diction of pneumonia in a pediatric emergency department. Pediat rics. 2011; 128: 246–253.
6. Bilkis M. D., Gorgal N., Carbone M. et al. Validation and development of a clinical prediction rule in clinically suspected communityacquired pneumonia. Pediatr. Emerg. Care. 2010; 26: 399–415.
7. Neuman M. I., Lee E. Y., Bixby S. et al. Variability of the interpretation of chest radiographs for the diagnosis of pneumo nia in children. J. Hosp. Med. 2011.
8. Esposito S., Principi N. Unsolved problems in the approach to pediatric community-acquired pneumonia. Curr. Opin. Infect. Dis. 2012; 25: 286–291.
9. Ayieko P., English M. In children aged 2–59 months with pneumonia, which clinical signs best predict hypoxaemia? J. Trop. Pediatr. 2006; 52: 307–310.
10. Thompson M., Coad N., Harnden A. et al. How well do vital signs identify children with serious infections in paediatric emergency care? Arch. Dis. Child. 2009; 94: 888–893.
11. Flood R. G., Badik J., Aronoff S. C. The utility of serum C-reactive protein in differentiating bacterial from nonbacterial pneumonia in children: a metaanalysis of 1230 children. Pediatr. Infect. Dis. J. 2008; 27: 95–99.
12. Тhompson М., A. van den Bruel, Verbakel J. Systematic review and validation of prediction rules for identifying children with serious infections in emergency departments and urgent-access primary care. Health Technology Assessment. 2012; 16: 15.
13. Burkhardt O., Ewig S., Haagen U. et al. Procalcitonin guidance and reduction of antibiotic use in acute respiratory tract infection. Eur. Respir. J. 2010; 36: 601–607.
14. Khan D. A., Rahman A., Khan F. A. Is procalcitonin better than C-reactive protein for early diagnosis of bacterial pneumonia in children? J. Clin. Lab. Anal. 2010; 24: 1–5.
15. Бакрадзе М. Д. Новые лечебно-диагностические и организационные технологии ведения детей с острыми лихорадочными заболеваниями. Автореф. дис. … докт. мед. наук. М. 2009. 42 с.
16. Blasi F., Stolz D., Piffer F. Biomarkers in lower respiratory tract infections. Pulmonary Pharmacology & Therapeutics. 2010; 23: 501–507.
17. Horie М., Ugajin М., Suzuki М. Diagnostic and Prognostic Value of Procalcitonin in Community-Acquired Pneumonia. Am. J. Med. Sci. 2012; 343 (1): 30–35.
18. Laurichesse H., Grimaud O., Waight P. et al. Pneumococcal bacteraemia and meningitis in England and Wales, 1993 to 1995. Commun. Dis. Public Health. 1998; 1: 22–27.
19. Lahti E., Peltola V., Waris M. et al. Induced sputum in the diagnosis of childhood community-acquired pneumonia. Thorax. 2009; 64: 252–257.
20. Shah S. S., Dugan M. H., Bell L. M. et al. Blood cultures in the emergency department evaluation of childhood pneumonia. Pediatr. Infect. Dis. J. 2011; 30: 475–479.
21. Resti M., Micheli A., Moriondo M. et al. Comparison of the effect of antibiotic treatment on the possibility of diagnosing invasive pneumococcal disease by culture or molecular methods: a prospective, observational study of children and adolescents with proven pneumococcal infection. Clin. Ther. 2009; 31: 1266–1273.
22. Харит С. М., Сидоренко С. В., Рулева А. А. и др. Распро страненность пневмококковых пневмоний и отитов у детей младшего возраста (предварительные данные). Вопр. совр. пед. 2011; 6: 103–107.
23. Marchese A., Esposito S., Coppo E. et al. Detection of Streptococcus pneumoniae and identification of pneumococcal serotypes by real-time polymerase chain reaction using blood samples from Italian children 5 years of age with communityacquired pneumonia. Microb. Drug Resist. 2011; 17: 419–424.
24. Thurman K. A., Walter N. D., Schwartz S. B. et al. Comparison of laboratory diagnostic procedures for detection of Mycoplasma pneumoniae in community outbreaks. Clin. Infect. Dis. 2009; 48: 1244–1249. 25. Jansen R. R., Wieringa J., Koekkoek S. M. et al. Frequent detec tion of respiratory viruses without symptoms: toward defining clinically relevant cutoff values. J. Clin. Microbiol. 2011; 49: 2631–2636.
25. Morens D. M., Taubenberger J. K., Fauci A. S. Predominant role of bacterial pneumonia as a cause of death in pandemic influenza: implications for pandemic influenza preparedness. J. Infect. Dis. 2008; 198: 962–970.
26. Copelovitch L., Kaplan B. Streptococcus pneumoniae-associated hemolytic uremic syndrome: classification and the emergence of serotype 19A. Pediatrics. 2010; 125: 174–182.
27. Recommendations for management of common childhood conditions: evidence for technical update of pocket book recommendations: newborn conditions, dysentery, pneumonia, oxygen use and delivery, common causes of fever, severe acute malnutrition and supportive care. World Health Organization. 2012. URL: http://www.who.int.
28. Практическое руководство по антиинфекционной химиотера- пии / под ред. Л. С. Страчунского, Ю. Б. Белоусова, С. Н. Козлова. Смоленск: МАКМАХ. 2007. 464 с.
29. WHO Weekly Epidemiological Record. 2007, No. 1/2, 2007; 82: 93–104. World Health Organization. URL: http://www.who.int/wer.
30. Сидоренко С. В., Лобзин Ю. В., Харит С. М. и др. Пневмококковая инфекция и современные возможности ее профилактики — эпидемиологический обзор ситуации в мире и в России. Вопр. совр. пед. 2010; 9 (1): 62–69.
31. Reinert R. R., Paradiso P., Fritzel B. Advances in pneumococcal vaccines: the 13-valent pneumococcal conjugate vaccine received market authorization in Europe. Exp. Rev. Vacc. 2010; 9: 229–236.
32. Liua Y., Wanga H., Chen M. Serotype distribution and antimicrobial resistance patterns of Streptococcus pneumoniae isolated from children in China younger than 5 years. Diagn. Microbiol. Infect. Dis. 2008; 61: 256–263.
33. Jourdain S., Smeesters P. R., Denis O. et al. Differences in nasopharyngeal bacterial carriage in preschool children from different socio-economic origins. Clin. Microbiol. Infect. 2010.
34. Катосова Л. К., Таточенко В. К., Арова А. А. и др. Серотипы S. pneumoniae у детей, больных острой пневмонией и плевритом. Журн. микробиол. эпидемиол. иммунобиол. 1990; 5: 23–28.
35. Таточенко В. К., Катосова Л. К., Уланова М. А. и др. Перио ди- ческие и региональные особенности серотипового спектра пневмококков у детей с респираторными заболеваниями и здоровых носителей. Журн. микробиол. эпидемиол. иммунобиол. 1994; 3: 3–10.
36. Маянский Н. А., Алябьева Н.М., Катосова Л. К. и др. Опре- де ление капсульных серотипов пневмококка методом мульти- плексной ПЦР. Вопр. диагн. пед. 2010; 2 (6): 6–10.
37. Isaacman D. J., McIntosh E. D., Reinert R. R. Burden of invasive pneumococcal disease and serotype distribution among Strep tococcus pneumoniae isolates in young children in Europe: impact of the 7-valent pneumococcal conjugate vaccine and considerations for future conjugate vaccines. Int. J. Infect. Dis. 2010; 14: 197–209.
38. Катосова Л. К., Таточенко В. К., Арова А. А. и др. Серотипы S. pneumoniae у детей, больных острой пневмонией и плевритом. Журн. микробиол. эпидемиол. иммунобиол. 1990; 5: 23–28.
39. Савина Т. А., Сидоренко С. В. Антибиотики и химиотерапия. 2011; 56 (5–6).
Review
For citations:
Namazova-Baranova L.S., Kulichenko T.V., Malakhova A.E., Starovoitova E.V., Bakradze M.D., Chashchina I.L., Mitushin I.L. PNEUMOCOCCAL INFECTION IN CHILDREN: EVERYDAY PRACTICE. Current Pediatrics. 2012;11(4):65-72. (In Russ.) https://doi.org/10.15690/vsp.v11i4.361
Views:
1009
Email this article 
